Company News

Sabinsa’s Biotech Site Earns USP GMP Audited Status

Author Image

By: TOM BRANNA

Editor

INDIA: The Sami-Sabinsa Group’s Nelamangala biotechnology site in Bengaluru, India has been audited by the US Pharmacopeia (USP) and received a GMP compliance certificate. This site produces Sabinsa’s probiotics, enzyme blends as well as supercritical fluid extraction of various botanicals. The certificate recognizes that the site operates GMP quality systems which meet the requirements set forth in 21 CFR Part 117 Current Good Manufacturing Practice, Hazard Analysis and Risk-Based Preventive...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters